Sensiva Health, which owns and operates a state-of-the-art molecular laboratory and ISO certified diagnostics manufacturing facility, announced their partnership with PointClickCare and has completed a full integration on the PCC marketplace. With this in place, PCC users across the country can now connect directly to their laboratory and view patient results in real-time, directly in the PointClickCare EHR.
Read MoreAccording to Florida’s Department of Health (DOH), Florida Governor Ron DeSantis on Tuesday ordered state health agencies to cut their ties with Quest Diagnostics, one of the country’s largest test labs, after the company failed to report nearly 75,000 coronavirus tests in a timely manner. Most of the unreported tests, the DOH said, are two-weeks old and some date back as many as five months. Similar backlogs with other labs are occurring in states throughout the U.S.
Read MoreIt’s one thing to have false positive, but false negative – that’s when you’re failing the patient. At the height of the breakout, I didn’t believe any result. I looked at the patients and told them, this result is negative but I’m still going to treat you because you have all the symptoms.
Read MoreSensiva can provide Caribbean healthcare providers with risk exposure information and guidance immediately after results are received via an online report, or by phone through Sensiva’s proprietary mobile application. While both clearly explain the test results, a team of telemedicine professionals will also be available to answer questions via live chat, email, or phone support.
Read MoreCormeum Lab Services LLC, a high-volume Clinical Laboratory Improvement Amendments (CLIA) certified medical lab based in Marrero, Louisiana, recently received approval of its Emergency Use Authorization (EUA) from the US Food and Drug Administration (FDA) for a PCR-based SARS-CoV-2 test. In addition, based on the approximately 175 clinical samples submitted to the FDA as part of its EUA approval process, Cormeum's testing solution received a 100% accuracy rating for both specificity and sensitivity.
Read MoreSensiva has sought expedited examination of its patent application, and through its affiliate Cormeum Lab Services, LLC, has filed for Emergency Use Authorization through the U.S. Food and Drug Administration.
Read MoreAs a company solely focused on COVID-19 testing, and that is aggressively adding throughput, Sensiva currently has the ability to manufacture, deliver and process over 100,000 tests per week and anticipates having the ability to increase up to 500,000 tests per week within approximately the next 45 days.
Read More